The Clinical Core provides the Projects with data from epidemiological, neuropsychological, medical and physical measures. The Core is responsible for obtaining informed consent for participation in the EAS and for participation in the brain donation program. The Core's primary function is characterization of EAS subjects through baseline and annual follow-up clinical and neuropsychological evaluations, including the assignment of cognitive and dementia diagnoses. All subjects undergo an in-person Clinical Core evaluation at baseline and subsequent 12-month intervals. The Core also conducts Consensus Case Conferences to assign clinical cognitive outcomes for each subject at each Wave (annual evaluation). Clinical outcomes assigned include: 1) Diagnosis of DSM-IV 'Dementia'versus 'No Dementia';2) for subjects with dementia, subtypes are diagnoses using standard criteria;and 3) Intermediate States of Cognitive Impairment (amnestic Mild Cognitive Impairment, non-amnestic Mild Cognitive Impairment). The Clinical Core cooperates with the Administrative Core to collect follow-up medical and neuropsychological information for study subjects no longer able to return for in-person evaluations. Data from the Clinical Core are used to determine subject eligibility for participation in Projects. Finally, the Clinical Core collects, distributes, and banks biological specimens for current and future assays.
The Clinical Core collects epidemiological, neuropsychological and neurological data to service research projects. These data are used to assign diagnoses, to develop other outcome variables, correlate with neuropathologic findings and experimental neuropsychological procedures and locomotor outcomes. The Clinical Core ascertains all the confounders and effect modifiers of dementia risk.
|Hall, Charles B; Lipton, Richard B; Katz, Mindy J et al. (2015) Correcting Bias Caused by Missing Data in the Estimate of the Effect of Apolipoprotein ?4 on Cognitive Decline. J Int Neuropsychol Soc 21:85-90|
|Ezzati, Ali; Zimmerman, Molly E; Katz, Mindy J et al. (2014) Hippocampal subfields differentially correlate with chronic pain in older adults. Brain Res 1573:54-62|
|Davidai, G; Cotton, D; Gorelick, P et al. (2014) Dipyridamole-induced headache and lower recurrence risk in secondary prevention of ischaemic stroke: a post hoc analysis. Eur J Neurol 21:1311-7|
|Aurora, S K; Dodick, D W; Diener, H-C et al. (2014) OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program. Acta Neurol Scand 129:61-70|
|Ayers, Emmeline I; Tow, Amanda C; Holtzer, Roee et al. (2014) Walking while talking and falls in aging. Gerontology 60:108-13|
|Blumen, Helena M; Holtzer, Roee; Brown, Lucy L et al. (2014) Behavioral and neural correlates of imagined walking and walking-while-talking in the elderly. Hum Brain Mapp 35:4090-104|
|Lipton, Richard B; Buse, Dawn C; Hall, Charles B et al. (2014) Reduction in perceived stress as a migraine trigger: testing the "let-down headache" hypothesis. Neurology 82:1395-401|
|Lipton, Richard B; Serrano, Daniel; Pavlovic, Jelena M et al. (2014) Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study. Headache 54:830-49|
|Kouri, Naomi; Carlomagno, Yari; Baker, Matthew et al. (2014) Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration. Acta Neuropathol 127:271-82|
|Murray, Melissa E; Cannon, Ashley; Graff-Radford, Neill R et al. (2014) Differential clinicopathologic and genetic features of late-onset amnestic dementias. Acta Neuropathol 128:411-21|
Showing the most recent 10 out of 138 publications